Invasive breast carcinoma - IARC

1624. Lele SB, Piver MS, Barlow JJ,
Tsukada Y (1978). Squamous cell carcinoma
arising in ovarian endometriosis.
Gynecol Oncol 6: 290-293.
1625. Lemoine NR, Hall PA (1986). Epithelial
tumors metastatic to the uterine cervix. A
study of 33 cases and review of the literature.
Cancer 57: 2002-2005.
1626. Lenehan PM, Meffe F, Lickrish GM
(1986). Vaginal intraepithelial neoplasia:
biologic aspects and management. Obstet
Gynecol 68: 333-337.
1627. Lenfant-Pejovic MH, Mlika-Cabanne
N, Bouchardy C, Auquier A (1990). Risk factors
for male breast cancer: a Franco-
Swiss case-control study. Int J Cancer 45:
661-665.
1628. Leoncini L (1980). [Brenner tumor of
the broad ligament]. Arch De Vecchi Anat
Patol 64: 97-102.
1629. Leong AS, Williams JA (1985).
Mucoepidermoid carcinoma of the breast:
high grade variant. Pathology 17: 516-521.
1630. Leppien G (1987). Non-uterine gynecological
sarcomas. Arch Gynecol Obstet
241: 25-32.
1631. Lerner LB, Andrews SJ, Gonzalez JL,
Heaney JA, Currie JL (1999). Vulvar metastases
secondary to transitional cell carcinoma
of the bladder. A case report. J
Reprod Med 44: 729-732.
1632. Lesser ML, Rosen PP, Kinne DW
(1982). Multicentricity and bilaterality in
invasive breast carcinoma. Surgery 91:
234-240.
1633. Lesueur GC, Brown RW, Bhathal PS
(1983). Incidence of perilobular hemangioma
in the female breast. Arch Pathol
Lab Med 107: 308-310.
1634. Leuchter RS, Hacker NF, Voet RL,
Berek JS, Townsend DE, Lagasse LD
(1982). Primary carcinoma of the Bartholin
gland: a report of 14 cases and review of
the literature. Obstet Gynecol 60: 361-368.
1635. Leung WY, Schwartz PE, Ng HT,
Yang-Feng TL (1990). Trisomy 12 in benign
fibroma and granulosa cell tumor of the
ovary. Gynecol Oncol 38: 28-31.
1636. Levi F, La Vecchia C, Gulie C, Negri E
(1993). Dietary factors and breast cancer
risk in Vaud, Switzerland. Nutr Cancer 19:
327-335.
1637. Levi F, Lucchini F, Negri E, Boyle P, La
Vecchia C (1999). Cancer mortality in
Europe, 1990-1994, and an overview of
trends from 1955 to 1994. Eur J Cancer 35:
1477-1516.
1638. Levi F, Lucchini F, Negri E, Franceschi
S, La Vecchia C (2000). Cervical cancer
mortality in young women in Europe: patterns
and trends. Eur J Cancer 36: 2266-
2271.
1639. Levi F, Pasche C, Lucchini F, La
Vecchia C (2001). Dietary intake of selected
micronutrients and breast-cancer risk.
Int J Cancer 91: 260-263.
1640. Levi F, Randimbison L, Te VC, La
Vecchia C (1994). Incidence of breast can -
cer in women with fibroadenoma. Int J
Cancer 57: 681-683.
1641. Levine PH, Steinhorn SC, Ries LG,
Aron JL (1985). Inflammatory breast cancer:
the experience of the surveillance,
epidemiology, and end results (SEER) program.
J Natl Cancer Inst 74: 291-297.
1642. Levine RL, Cargile CB, Blazes MS,
van Rees B, Kurman RJ, Ellenson LH (1998).
PTEN mutations and microsatellite instability
in complex atypical hyperplasia, a
precursor lesion to uterine endometrioid
carcinoma. Cancer Res 58: 3254-3258.
1643. Levrero M, De Laurenzi V, Costanzo
A, Gong J, Wang JY, Melino G (2000). The
p53/p63/p73 family of transcription factors:
overlapping and distinct functions. J Cell
Sci 113: 1661-1670.
1644. Levy-Lahad E, Lahad A, Eisenberg S,
Dagan E, Paperna T, Kasinetz L, Catane R,
Kaufman B, Beller U, Renbaum P,
Gershoni-Baruch R (2001). A single
nucleotide polymorphism in the RAD51
gene modifies cancer risk in BRCA2 but
not BRCA1 carriers. Proc Natl Acad Sci
USA 98: 3232-3236.
1645. Lew WY (1993). Spindle cell lipoma of
the breast: a case report and literature
review. Diagn Cytopathol 9: 434-437.
1646. Lewis TL (1971). Colloid (mucus
secreting) carcinoma of the cervix. J
Obstet Gynaecol Br Commonw 78: 1128-
1132.
1647. Li CI, Anderson BO, Porter P, Holt SK,
Daling JR, Moe RE (2000). Changing incidence
rate of invasive lobular breast carcinoma
among older women. Cancer 8 8 :
2561-2569.
1648. Li CI, Weiss NS, Stanford JL, Daling
JR (2000). Hormone replacement therapy
in relation to risk of lobular and ductal
breast carcinoma in middle-aged women.
Cancer 88: 2570-2577.
1649. Li DM, Sun H (1997). TEP1, encoded
by a candidate tumor suppressor locus, is
a novel protein tyrosine phosphatase regulated
by transforming growth factor beta.
Cancer Res 57: 2124-2129.
1650. Li FP, Fraumeni JF Jr., Mulvihill JJ,
Blattner WA, Dreyfus MG, Tucker MA,
Miller RW (1988). A cancer family syndrome
in twenty-four kindreds. Cancer Res
48: 5358-5362.
1651. Li J, Yen C, Liaw D, Podsypanina K,
Bose S, Wang SI, Puc J, Miliaresis C,
Rodgers L, McCombie R, Bigner SH,
Giovanella BC, Ittmann M, Tycko B,
Hibshoosh H, Wigler MH, Parsons R (1997).
PTEN, a putative protein tyrosine phosphatase
gene mutated in human brain,
breast, and prostate cancer. Science 275:
1943-1947.
1652. Li S, Zimmerman RL, LiVolsi VA (1999).
Mixed malignant germ cell tumor of the fallopian
tube. Int J Gynecol Pathol 18: 183-
185.
1653. Liang SB, Sonobe H, Taguchi T,
Takeuchi T, Furihata M, Yuri K, Ohtsuki Y
(2001). Tetrasomy 12 in ovarian tumors of
thecoma-fibroma group: A fluorescence in
situ hybridization analysis using paraffin
sections. Pathol Int 51: 37-42.
1654. Liaw D, Marsh DJ, Li J, Dahia PL,
Wang SI, Zheng Z, Bose S, Call KM, Tsou
HC, Peacocke M, Eng C, Parsons R (1997).
Germline mutations of the PTEN gene in
Cowden disease, an inherited breast and
thyroid cancer syndrome. Nat Genet 16:
64-67.
1655. Liberman L (2000). Pathologic analysis
of sentinel lymph nodes in breast carcinoma.
Cancer 88: 971-977.
1656. Liberman L, Dershaw DD, Kaufman
RJ, Rosen PP (1992). Angiosarcoma of the
breast. Radiology 183: 649-654.
1657. Liberman L, Giess CS, Dershaw DD,
Louie DC, Deutch BM (1994). Non-Hodgkin
lymphoma of the breast: imaging characteristics
and correlation with histopathologic
findings. Radiology 192: 157-160.
1658. Lichtenstein P, Holm NV, Verkasalo
PK, Iliadou A, Kaprio J, Koskenvuo M,
Pukkala E, Skytthe A, Hemminki K (2000).
Environmental and heritable factors in the
causation of cancer--analyses of cohorts
of twins from Sweden, Denmark, and
Finland. N Engl J Med 343: 78-85.
1659. Lie AK, Skarsvag S, Skomedal H,
Haugen OA, Holm R (1999). Expression of
p53, MDM2, and p21 proteins in high-grade
cervical intraepithelial neoplasia and rela -
tionship to human papillomavirus infection.
Int J Gynecol Pathol 18: 5-11.
1660. Lifschitz-Mercer B, Walt H, Kushnir I,
Jacob N, Diener PA, Moll R, Czernobilsky B
(1995). Differentiation potential of ovarian
dysgerminoma: an immunohistochemical
study of 15 cases. Hum Pathol 26: 62-66.
1661. Lillemoe TJ, Perrone T, Norris HJ,
Dehner LP (1991). Myogenous phenotype
of epithelial-like areas in endometrial stromal
sarcomas. Arch Pathol Lab Med 115:
215-219.
1662. Lim CL, Walker MJ, Mehta RR, Das
Gupta TK (1986). Estrogen and antiestrogen
binding sites in desmoid tumors. Eur J
Cancer Clin Oncol 22: 583-587.
1663. Lin MC, Mutter GL, Trivijisilp P,
Boynton KA, Sun D, Crum CP (1998).
Patterns of allelic loss (LOH) in vulvar
squamous carcinomas and adjacent noninvasive
epithelia. Am J Pathol 152: 1313-
1318.
1664. Lin WM, Forgacs E, Warshal DP, Yeh
IT, Martin JS, Ashfaq R, Muller CY (1998).
Loss of heterozygosity and mutational
analysis of the PTEN/MMAC1 gene in syn -
chronous endometrial and ovarian carcinomas.
Clin Cancer Res 4: 2577-2583.
1665. Lin Y, Govindan R, Hess JL (1997).
Malignant hematopoietic breast tumors.
Am J Clin Pathol 107: 177-186.
1666. Lindblom A, Tannergard P, Werelius
B, Nordenskjold M (1993). Genetic mapping
of a second locus predisposing to
hereditary non-polyposis colon cancer.
Nat Genet 5: 279-282.
1667. Linder D, Power J (1970). Further evi -
dence for post-meiotic origin of teratomas
in the human female. Ann Hum Genet 34:
21-30.
1668. Linell F, Ljungberg O, Andersson I
(1980). Breast carcinoma. Aspects of early
stages, progression and related problems.
Acta Pathol Microbiol Scand Suppl 1-233.
1669. Lininger RA, Ashfaq R, Albores-
Saavedra J, Tavassoli FA (1997).
Transitional cell carcinoma of the
endometrium and endometrial carcinoma
with transitional cell differentiation.
Cancer 79: 1933-1943.
1670. Lininger RA, Fujii H, Man YG,
Gabrielson E, Tavassoli FA (1998).
Comparison of loss heterozygosity in primary
and recurrent ductal carcinoma in
situ of the breast. Mod Pathol 11: 1151-
1159.
1671. Lininger RA, Park WS, Man YG, Pham
T, MacGrogan G, Zhuang Z, Tavassoli FA
(1998). LOH at 16p13 is a novel chromosomal
alteration detected in benign and
malignant microdissected papillary neoplasms
of the breast. Hum Pathol 29: 1113-
1118.
1672. Lininger RA, Wistuba I, Gazdar A,
Koenig C, Tavassoli FA, Albores-Saavedra
J (1998). Human papillomavirus type 16 is
detected in transitional cell carcinomas
and squamotransitional cell carcinomas of
the cervix and endometrium. Cancer 83:
521-527.
1673. Lininger RA, Zhuang Z, Man Y, Park
WS, Emmert-Buck M, Tavassoli FA (1999).
Loss of heterozygosity is detected at chromosomes
1p35-36 (NB), 3p25 (VHL), 16p13
(TSC2/PKD1), and 17p13 (TP53) in microdissected
apocrine carcinomas of the breast.
Mod Pathol 12: 1083-1089.
1674. Lipkin SM, Wang V, Jacoby R,
Banerjee-Basu S, Baxevanis AD, Lynch
HT, Elliott RM, Collins FS (2000). MLH3: a
DNA mismatch repair gene associated
with mammalian microsatellite instability.
Nat Genet 24: 27-35.
1675. Lipper S, Wilson C, Copeland KC
(1981). Pseudogynecomastia due to neurofibromatosis:
a light microscopic and
ultrastructural study. Hum Pathol 12: 755-
759.
1676. Lipworth L, Hsieh CC, Wide L, Ekbom
A, Yu SZ, Yu GP, Xu B, Hellerstein S,
Carlstrom K, Trichopoulos D, Adami HO
(1999). Maternal pregnancy hormone levels
in an area with a high incidence
(Boston, USA) and in an area with a low
incidence (Shanghai, China) of breast cancer.
Br J Cancer 79: 7-12.
1677. Lissoni A, Cormio G, Perego P,
Gabriele A, Cantu MG, Bratina G (1997).
Conservative management of endometrial
stromal sarcoma en young women. Int J
Gynecol Cancer 7: 364-367.
1678. Little MP, Boice JDJ (1999).
Comparison of breast cancer incidence in
the Massachusetts tuberculosis fluoroscopy
cohort and in the Japanese atomic
bomb survivors. Radiat Res 151: 218-224.
1679. Liu B, Nicolaides NC, Markowitz S,
Willson JK, Parsons RE, Jen J,
Papadopolous N, Peltomaki P, de la
Chapelle A, Hamilton SR, Kinzler KW,
Vogelstein B (1995). Mismatch repair gene
defects in sporadic colorectal cancers
with microsatellite instability. Nat Genet 9:
48-55.
1680. Liu B, Parsons RE, Hamilton SR,
Petersen GM, Lynch HT, Watson P,
Markowitz S, Willson JK, Green J, de la
Chapelle A, Kinzler KW, Vogelstein B
(1994). hMSH2 mutations in hereditary
nonpolyposis colorectal cancer kindreds.
Cancer Res 54: 4590-4594.
1681. Liu FS, Kohler MF, Marks JR, Bast RC
Jr., Boyd J, Berchuck A (1994). Mutation
and overexpression of the p53 tumor suppressor
gene frequently occurs in uterine
and ovarian sarcomas. Obstet Gynecol 83:
118-124.
1682. Liu MM (1988). Fibromyoma of the
vagina. Eur J Obstet Gynecol Reprod Biol
29: 321-328.
1683. Liu WM, Chen CJ, Kan YY, Chao KC,
Yuan CC, Ng HT (1989). Simultaneous
endometrioid carcinoma of the uterine
corpus and ovary. Zhonghua Yi Xue Za Zhi
(Taipei) 44: 38-44.
1684. LiVolsi VA, Kelsey JL, Fischer DB,
Holford TR, Mostow ED, Goldenberg IS
(1982). Effect of age at first childbirth on
risk of developing specific histologic subtype
of breast cancer. Cancer 49: 1937-
1940.
1685. Lloreta J, Prat J (1992). Endometrial
stromal nodule with smooth and skeletal
muscle components simulating stromal
sarcoma. Int J Gynecol Pathol 11: 293-298.
1686. Lobaccaro JM, Lumbroso S, Belon C,
Galtier-Dereure F, Bringer J, Lesimple T,
Namer M, Cutuli BF, Pujol H, Sultan C
(1993). Androgen receptor gene mutation
in male breast cancer. Hum Mol Genet 2:
1799-1802.
398 References